Mangoceuticals (MGRX) Inventory (2023 - 2024)

Mangoceuticals (MGRX) posted Inventory of -$18501.0 for Q4 2024, down 240.02% sequentially from $13213.0 in Q3 2024, and down 200.0% YoY from $18501.0 in Q1 2024.

Mangoceuticals (MGRX) Inventory (2023 - 2024) Analysis & Trends

Mangoceuticals has reported Inventory for 2 years, with the latest figure at -$18501.0 in Q4 2024.

  • Quarterly Inventory fell 200.0% year-over-year to -$18501.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$18501.0 (down 200.0% YoY) and the FY2024 annual result came in at -$18501.0, down 200.0% from the prior year.
  • Inventory declined to -$18501.0 in Q4 2024 per MGRX's latest filing, from $13213.0 in the prior quarter.
  • Over five years, Inventory peaked at $23494.0 in Q2 2023 and troughed at -$18501.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn -
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn 575.01 Mn
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn -
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn 52.62 Mn
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn 16.77 Mn
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn 341.00 Mn
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn -
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn -
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn -
10 Mangoceuticals 9.55 Mn 9.30 Mn 44,215.00 -

Historic Data

Download Data
DateValue
Dec 31, 2024 -18,501.00
Sep 30, 2024 13,213.00
Jun 30, 2024 14,019.00
Mar 31, 2024 14,452.00
Dec 31, 2023 18,501.00
Sep 30, 2023 21,581.00
Jun 30, 2023 23,494.00